[vc_row css=”.vc_custom_1522131798614{padding-bottom: 40px !important;}”][vc_column][vc_column_text css=”.vc_custom_1521025881928{padding-bottom: 20px !important;}”]Among top 15 Globally: Advanced Enzyme Technologies promoter Chandrakant Laxminarayan Rathi is responsible for managing the entire operations of the second largest enzyme manufacturing company in India.

Advanced Enzyme Technologies is among the top fifteen global enzyme companies, with a market share of around 0.9 per cent. The company is engaged in manufacturing, research and development and marketing more than 400 proprietary products, developed from 60 indigenous enzymes.

Advanced Enzyme Technologies was promoted by both Chandrakant and Vasant Laxminarayan Rathi, who have 70 years’ experience in the global enzyme industry. Rathi’s total annual compensation in 2016 was Rs 12,780,000. His current wealth is estimated at Rs 2,730 crore.

The company’s consolidated unaudited financial results for the six months ended September 30, 2016, show its income from operations to be Rs 185.31 crore against Rs 138.85 crore for the same period, a year ago. Advanced Enzyme Technologies earned a net profit of Rs 57.41 crore in the first six months of the ongoing financial year, compared to Rs 33.49 crore in the first half of 2015-16.

The company has clocked a 14.4 per cent CAGR in sales between 2012 and 2016. Its EBITDA grew 22.1 per cent CAGR during the period. Its net profit for the period grew at 23.9 per cent CAGR. Advanced Enzyme Technologies’ top 10 customers accounted for 41.5 per cent of its total revenue in the 2016-17 financial year.

In July 2016, the company made an initial public offer to rid itself of some of its debt. At the launch of the public issue, the company’s promoter and managing director, C. L. Rathi said, “Our debt on the books stands at Rs 101 crore at present, out of which Rs 40 crore will get reduced from the IPO. We have also been regularly paying other debts, which are on the books. So we expect the debt to be less than Rs 50 crore going forward. Also, it (the company) could be totally debt free in a couple of years.”
– Monica Behura[/vc_column_text][/vc_column][/vc_row][vc_row full_width=”stretch_row” bg_type=”image” parallax_style=”vcpb-default” bg_image_new=”id^1823|url^https://advancedenzymes.us/wp-content/uploads/2016/02/footer-form-banner.jpg|caption^null|alt^null|title^footer-form-banner|description^null” bg_img_attach=”fixed” bg_override=”full” enable_overlay=”enable_overlay_value” overlay_color=”rgba(10,10,10,0.72)” overlay_pattern=”09.png” overlay_pattern_attachment=”fixed” css=”.vc_custom_1519717151392{margin-bottom: -60px !important;padding-top: 50px !important;padding-bottom: 40px !important;}”][vc_column]

[vc_row css=”.vc_custom_1522131538164{padding-bottom: 40px !important;}”][vc_column][vc_column_text css=”.vc_custom_1521096895895{padding-bottom: 25px !important;}”]Advanced Enzymes, India’s leading manufacturer of industrial enzymes, has set up an ultra-modern manufacturing facility near Indore. The State-of -the- Art plant has been built with an investment of over Rs 75 Crores and incorporates the topmost technological innovations available in the enzyme industry globally.

The new plant has an area admeasuring 38400 Sq. Metres and has enabled Advanced Enzymes to treble its fermentation capacity from 120 m3 to 400 m3. The facility is also indigenously designed in such a way, that a further fermentation capacity of 600m3 can be added up in the same plant with minimal incremental investment in the near future.

Mr. C L Rathi, Managing Director, Advanced Enzymes said, “The new facility will help us cater to various industries and increase our global Foot Print” With the new plant in place Advanced Enzymes expects to meet the growing demand for its products globally. As such 65% of its total revenues are already generated from its international operations and this figure is expected to grow still higher in the near future.

About Advanced Enzymes technologies Limited.

Established in 1989, Advanced Enzyme Technologies Limited is South Asia’s largest industrial enzyme manufacturer and is amongst the leading players in this field globally. Catering to a worldwide market in geographies like Europe, America, China and India, it specializes in providing customized, eco-safe solutions across various industries. Some of the areas that it focuses on are human healthcare, food processing, animal feed, textiles, paper and bio-energy. An R&D focused company with approximately 10% of earnings being ploughed back into research & development activities; it is poised to file for 6 patents this year with 17 being filed so far & 9 being awarded already. The company is also the largest manufacturer of serratiopeptidase, an anti-inflammatory drug, having perfected the art of manufacturing this enzyme over the past 18 years.[/vc_column_text][/vc_column][/vc_row][vc_row full_width=”stretch_row” bg_type=”image” parallax_style=”vcpb-default” bg_image_new=”id^1823|url^https://advancedenzymes.us/wp-content/uploads/2016/02/footer-form-banner.jpg|caption^null|alt^null|title^footer-form-banner|description^null” bg_img_attach=”fixed” bg_override=”full” enable_overlay=”enable_overlay_value” overlay_color=”rgba(10,10,10,0.72)” overlay_pattern=”09.png” overlay_pattern_attachment=”fixed” css=”.vc_custom_1519717151392{margin-bottom: -60px !important;padding-top: 50px !important;padding-bottom: 40px !important;}”][vc_column]